American Journal of Kidney Diseases
Volume 42, Issue 2 , Pages 350-354 , August 2003

Depression and its association with peritonitis in long-term peritoneal dialysis patients

  • Laura Troidle, PA

      Affiliations

    • Yale University School of Medicine, New Haven, CT, USA
    • New Haven CAPD, Renal Research Institute, New Haven, CT, USA
    • Portland Veterans Administration Medical Center, Portland, OR, USA
    • ,
  • Suzanne Watnick, MD

      Affiliations

    • Department of Medicine, Hospital of St Raphael, New Haven, CT, USA
    • ,
  • Diane B Wuerth, LSW

      Affiliations

    • New Haven CAPD, Renal Research Institute, New Haven, CT, USA
    • ,
  • Nancy Gorban-Brennan, LPN

      Affiliations

    • New Haven CAPD, Renal Research Institute, New Haven, CT, USA
    • ,
  • Alan S Kliger, MD

      Affiliations

    • Yale University School of Medicine, New Haven, CT, USA
    • New Haven CAPD, Renal Research Institute, New Haven, CT, USA
    • Portland Veterans Administration Medical Center, Portland, OR, USA
    • ,
  • Fredric O Finkelstein, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Fredric O. Finkelstein, MD, 136 Sherman Ave, New Haven, CT 06510, USA
    • Yale University School of Medicine, New Haven, CT, USA
    • New Haven CAPD, Renal Research Institute, New Haven, CT, USA
    • Portland Veterans Administration Medical Center, Portland, OR, USA

Received 26 December 2002 ,Accepted 23 April 2003.

References 

  1. Troidle LK, Kliger AS, Finkelstein FO. Challenges of managing chronic peritoneal dialysis-associated peritonitis. Perit Dial Int. 1999;19:315–318
  2. Bernardini J. Nolph KDA randomized trial of Staphylococus aureus prophylaxis in peritoneal dialysis patients (Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin). Am J Kidney Dis. 1996;27:695–700
  3. Thodis E, Bhaskaran S, Pasadakis P, et al.  Decrease in Staphylococcus aureus exit-site infection and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit-site. Perit Dial Int. 1998;18:261–270
  4. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK. A prospective randomized control study of oral nystatin prophylaxis in Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1996;28:549–552
  5. Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis. 2002;39:1278–1286
  6. Juergensen PH, Wuerth D, Juergensen DM, et al.  Psychological factors and incidence of peritonitis. Adv Perit Dial. 1996;12:196–198
  7. Kimmel PL, Weihs KL, Peterson RA. Survival in hemodialysis patients (The role of depression). J Am Soc Nephrol. 1993;4:12–27
  8. Finkelstein FO, Finkelstein SH. Depression in chronic dialysis patients (Assessment and treatment). Nephrol Dial Transplant. 2000;15:1911–1913
  9. Kimmel PL. Psychosocial factors in dialysis patients. Kidney Int. 2001;59:1599–1613
  10. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18 month survival after myocardial infarction. Circulation. 1996;91:999–1005
  11. Covinsky KE, Kahana E, Chin MH, et al.  Depressive symptoms and 3-year mortality in older hospitalized patients. Ann Intern Med. 1999;130:563–569
  12. Herrmann C, Brand-Driehorst S, Kaminsky B, Leibing E, Staats H, Ruger U. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical in-patients. Psychosom Med. 1998;60:570–577
  13. Roach MJ, Connors AF, Dawson NV, et al.  Depressed mood and survival in seriously ill hospitalized adults. Arch Intern Med. 1998;158:397–404
  14. Kimmel PL, Peterson RA, Weihs KL. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis patients. Kidney Int. 2000;57:2093–2098
  15. Lopes AA, Bragg J, Young E, et al.  Depression as a predictor of mortality and hospitalization among hemodialysis patients in the US and Europe. Kidney Int. 2002;62:199–207
  16. Troidle L, Kliger AS, Gorban-Brennan N, Fikrig M, Golden M, Finkelstein FO. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int. 1996;50:1368–1372
  17. Wuerth D, Finkelstein SH, Ciarcia J, Peterson R, Kliger AS, Finkelstein FO. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis. 2001;37:1011–1017
  18. Watnick S, Kirwin P, Mahnensmith R, Concato J. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis. 2003;41:105–110
  19. Troidle L, Gorban-Brennan N, Kliger AS, Finkelstein F. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis. 1998;32:623–628
  20. Troidle LK, Gorban-Brennan N, Kliger AS, Finkelstein FO. Continuous cycler therapy, manual peritoneal dialysis therapy and peritonitis. Adv Perit Dial. 1998;14:127–130
  21. Kiecolt-Glaser JK, Glaser R. Depression and immune function (Central pathways to morbidity and mortality). J Psychosom Res. 2002;53:873–876
  22. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause, 1990-2020 (Global Burden of Disease Study). Lancet. 1997;349:1498–1504
  23. Christensen AJ, Wiebe JS, Smith TW, et al.  Predictors of survival among hemodialysis patients (Effect of perceived family support). Health Psychol. 1994;13:521–525
  24. Peterson RA, Kimmel PL, Sacks CR, et al.  Depression, perception of illness and mortality in patients with end-stage renal disease. Int J Psychiatry Med. 1991;21:343–354
  25. Scott J. Treatment of depression. N Engl J Med. 2000;342:1518–1520

PII: S0272-6386(03)00661-9

doi: 10.1016/S0272-6386(03)00661-9

American Journal of Kidney Diseases
Volume 42, Issue 2 , Pages 350-354 , August 2003

Article Tools